vs

Side-by-side financial comparison of Kosmos Energy Ltd. (KOS) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $294.6M, roughly 1.1× Kosmos Energy Ltd.). On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs -25.9%).

Kosmos Energy is an American upstream oil company founded and based in Dallas, Texas. While previously incorporated in Bermuda, Kosmos has reincorporated in Delaware. The company holds production and development operations offshore Ghana, Equatorial Guinea, and Gulf of Mexico, while holding a development project offshore Mauritania and Senegal, and exploration licenses offshore Namibia, São Tomé and Príncipe and Suriname. It was previously involved in exploration offshore Morocco and Western ...

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

KOS vs MDGL — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.1× larger
MDGL
$321.1M
$294.6M
KOS
Growing faster (revenue YoY)
MDGL
MDGL
+236.7% gap
MDGL
210.8%
-25.9%
KOS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KOS
KOS
MDGL
MDGL
Revenue
$294.6M
$321.1M
Net Profit
$-58.6M
Gross Margin
Operating Margin
-125.7%
-18.6%
Net Margin
-18.2%
Revenue YoY
-25.9%
210.8%
Net Profit YoY
1.4%
EPS (diluted)
$-0.80
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KOS
KOS
MDGL
MDGL
Q4 25
$294.6M
$321.1M
Q3 25
$311.0M
$287.3M
Q2 25
$392.6M
$212.8M
Q1 25
$290.1M
$137.3M
Q4 24
$397.6M
$103.3M
Q3 24
$407.8M
$62.2M
Q2 24
$447.8M
Q1 24
$422.3M
$0
Net Profit
KOS
KOS
MDGL
MDGL
Q4 25
$-58.6M
Q3 25
$-124.3M
$-114.2M
Q2 25
$-87.7M
$-42.3M
Q1 25
$-110.6M
$-73.2M
Q4 24
$-59.4M
Q3 24
$45.0M
$-107.0M
Q2 24
$59.8M
Q1 24
$91.7M
$-147.5M
Gross Margin
KOS
KOS
MDGL
MDGL
Q4 25
Q3 25
Q2 25
Q1 25
96.7%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
KOS
KOS
MDGL
MDGL
Q4 25
-125.7%
-18.6%
Q3 25
-34.2%
-39.7%
Q2 25
-16.2%
-22.2%
Q1 25
-32.4%
-57.8%
Q4 24
-8.5%
-64.8%
Q3 24
26.1%
-187.1%
Q2 24
30.2%
Q1 24
33.6%
Net Margin
KOS
KOS
MDGL
MDGL
Q4 25
-18.2%
Q3 25
-40.0%
-39.8%
Q2 25
-22.3%
-19.9%
Q1 25
-38.1%
-53.4%
Q4 24
-57.5%
Q3 24
11.0%
-172.0%
Q2 24
13.3%
Q1 24
21.7%
EPS (diluted)
KOS
KOS
MDGL
MDGL
Q4 25
$-0.80
$-2.55
Q3 25
$-0.26
$-5.08
Q2 25
$-0.18
$-1.90
Q1 25
$-0.23
$-3.32
Q4 24
$0.00
$-2.50
Q3 24
$0.09
$-4.92
Q2 24
$0.12
Q1 24
$0.19
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KOS
KOS
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$91.5M
$198.7M
Total DebtLower is stronger
$3.1B
$339.9M
Stockholders' EquityBook value
$528.6M
$602.7M
Total Assets
$4.7B
$1.3B
Debt / EquityLower = less leverage
5.78×
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KOS
KOS
MDGL
MDGL
Q4 25
$91.5M
$198.7M
Q3 25
$64.0M
$295.7M
Q2 25
$51.7M
$186.2M
Q1 25
$49.8M
$183.6M
Q4 24
$85.0M
$100.0M
Q3 24
$51.6M
$232.7M
Q2 24
$173.8M
Q1 24
$254.3M
$622.5M
Total Debt
KOS
KOS
MDGL
MDGL
Q4 25
$3.1B
$339.9M
Q3 25
$3.0B
$339.8M
Q2 25
$2.9B
$118.4M
Q1 25
$118.0M
Q4 24
$2.7B
$117.6M
Q3 24
$117.1M
Q2 24
Q1 24
$116.1M
Stockholders' Equity
KOS
KOS
MDGL
MDGL
Q4 25
$528.6M
$602.7M
Q3 25
$898.8M
$625.7M
Q2 25
$1.0B
$696.0M
Q1 25
$1.1B
$710.6M
Q4 24
$1.2B
$754.4M
Q3 24
$1.2B
$777.2M
Q2 24
$1.1B
Q1 24
$1.1B
$850.8M
Total Assets
KOS
KOS
MDGL
MDGL
Q4 25
$4.7B
$1.3B
Q3 25
$5.1B
$1.4B
Q2 25
$5.2B
$1.0B
Q1 25
$5.3B
$996.6M
Q4 24
$5.3B
$1.0B
Q3 24
$5.5B
$1.1B
Q2 24
$5.4B
Q1 24
$5.4B
$1.1B
Debt / Equity
KOS
KOS
MDGL
MDGL
Q4 25
5.78×
0.56×
Q3 25
3.31×
0.54×
Q2 25
2.80×
0.17×
Q1 25
0.17×
Q4 24
2.29×
0.16×
Q3 24
0.15×
Q2 24
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KOS
KOS
MDGL
MDGL
Operating Cash FlowLast quarter
$35.3M
$-133.5M
Free Cash FlowOCF − Capex
$-133.8M
FCF MarginFCF / Revenue
-41.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KOS
KOS
MDGL
MDGL
Q4 25
$35.3M
$-133.5M
Q3 25
$-27.6M
$79.8M
Q2 25
$127.2M
$-47.1M
Q1 25
$-888.0K
$-88.9M
Q4 24
$175.7M
$-104.5M
Q3 24
$6.3M
$-67.0M
Q2 24
$223.7M
Q1 24
$272.6M
$-149.2M
Free Cash Flow
KOS
KOS
MDGL
MDGL
Q4 25
$-133.8M
Q3 25
$79.0M
Q2 25
Q1 25
Q4 24
$-104.7M
Q3 24
$-67.8M
Q2 24
Q1 24
$-149.5M
FCF Margin
KOS
KOS
MDGL
MDGL
Q4 25
-41.7%
Q3 25
27.5%
Q2 25
Q1 25
Q4 24
-101.3%
Q3 24
-109.0%
Q2 24
Q1 24
Capex Intensity
KOS
KOS
MDGL
MDGL
Q4 25
0.1%
Q3 25
0.3%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.2%
Q3 24
1.3%
Q2 24
Q1 24
Cash Conversion
KOS
KOS
MDGL
MDGL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.14×
Q2 24
3.74×
Q1 24
2.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KOS
KOS

Ghana Segment$134.6M46%
Gulf Of America$80.7M27%
Mauritania And Senegal$54.9M19%
Equatorial Guinea Segment$24.3M8%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons